Thursday, July 24, 2014

How do journals like this even exist? Lovely spam! Wonderful spam!

Just got this email.  I consider this almost unquestionable proof that this is a spam open access journal (e.g., I don't do any work in this field ..)

Dear Dr. Jonathan A. Eisen,

Greetings from the Journal of Immunology and Immunotherapeutics!!!

At the outset, it’s your eminence & reputation in the quality of research field for which you have been invited to become Editorial Board member for our Journal.  We are aware of your reputation for quality of research and trustworthiness in the field of “Immunology and Immunotherapeutics” and that is why you are being requested to be an Editorial Board Member of our journal entitled “Journal of Immunology and Immunotherapeutics”.

 Please go through the URL for Journal home page:

IMPRINTS Online Publishing uses online review and editorial tracking systems of Editorial Manager® / IMPRINTS Group for quality review process. All works published by IMPRINTS Publishing Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. IMPRINTS Publishing Group supports the Bethesda statement on Open Access publishing.

We may again assure you of international quality and standards of our articles published in our journals, using state-of-the-art prominent reviewers and editorial board. We also assure you of our best co-operation always.

If you are interested, you are requested to send a recent passport size photo (to display at our website) and your C.V, Biography (150 words), Research Interests for our records.

We look forward to a close and lasting scientific relationship for the benefit of scientific community.

With best regards,

Stephen H
Managing Editor

Immunology and Immunotherapeutics

No comments:

Post a Comment

Most recent post

My Ode to Yolo Bypass

Gave my 1st ever talk about Yolo Bypass and my 1st ever talk about Nature Photography. Here it is ...